0001596771-15-000080.txt : 20151202
0001596771-15-000080.hdr.sgml : 20151202
20151202163335
ACCESSION NUMBER: 0001596771-15-000080
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20151201
FILED AS OF DATE: 20151202
DATE AS OF CHANGE: 20151202
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Diplomat Pharmacy, Inc.
CENTRAL INDEX KEY: 0001610092
STANDARD INDUSTRIAL CLASSIFICATION: RETAIL-DRUG STORES AND PROPRIETARY STORES [5912]
IRS NUMBER: 382063100
STATE OF INCORPORATION: MI
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 4100 S. SAGINAW ST.
CITY: FLINT
STATE: MI
ZIP: 48507
BUSINESS PHONE: 888-720-4450
MAIL ADDRESS:
STREET 1: 4100 S. SAGINAW ST.
CITY: FLINT
STATE: MI
ZIP: 48507
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Kadlec Gary W
CENTRAL INDEX KEY: 0001618898
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36677
FILM NUMBER: 151265107
MAIL ADDRESS:
STREET 1: 4100 S. SAGINAW STREET
CITY: FLINT
STATE: MI
ZIP: 48507
4
1
primary_doc.xml
PRIMARY DOCUMENT
X0306
4
2015-12-01
0
0001610092
Diplomat Pharmacy, Inc.
DPLO
0001618898
Kadlec Gary W
4100 S. SAGINAW STREET
FLINT
MI
48507
1
1
0
0
President
Common Stock
2015-12-01
4
M
0
30000
4.28
A
30000
D
Common Stock
2015-12-01
4
S
0
21140
34.7236
D
8860
D
Common Stock
2015-12-01
4
S
0
8860
35.4305
D
0
D
Employee Stock Option to Acquire Common Stock
4.28
2015-12-01
4
M
0
30000
0
D
2022-09-01
Common Stock
30000
182682
D
The sale was effected pursuant to a 10b5-1 trading plan initially adopted by the reporting person on June 24, 2015. The plan provides for monthly sales of 30,000 shares of common stock at the market price. Shares that are not sold in a particular month will be available for sale in subsequent months under the plan. No shares remain available for sale under the plan, which is set to expire on December 31, 2015.
The price represents the weighted average price of the multiple transactions reported on this line. The shares were sold at prices ranging from $34.29 to $35.09 per share. Upon request by the SEC staff, the issuer or any securityholder of the issuer, the reporting person will provide full information regarding the number of shares sold at each separate price.
The price represents the weighted average price of the multiple transactions reported on this line. The shares were sold at prices ranging from $35.11 to $35.84 per share. Upon request by the SEC staff, the issuer or any securityholder of the issuer, the reporting person will provide full information regarding the number of shares sold at each separate price.
The options were granted on September 1, 2012. The options began to vest in annual increments of 25% of the option grant on the one-year anniversary of the grant date, to be fully vested after four years. 75% of the options originally granted are currently vested and exercisable.
Jeffrey H. Kuras, Attorney-in-fact
2015-12-02